Abstract
Two adenosine deaminase inhibitors, erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) and 2-deoxycoformycin (2dCF) were evaluated for immunosuppressive properties in mouse and rat pancreatic islet cell allograft models. In the mouse model, administration of EHNA alone prolonged the survival of islet allografts. In the rat, neither EHNA or 2dCF alone permitted islet allograft survival. However, 2dCF, in combination with the deoxyadenosine analog adenine arabinoside provided significant rat islet allograft survival during a limited 8-day period of study.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 44-48 |
| Number of pages | 5 |
| Journal | Journal of Surgical Research |
| Volume | 28 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 1980 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Prolongation of mouse and rat pancreatic islet cell allografts by adenosine deaminase inhibitors and adenine arabinoside'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS